Acceptance, attitudes, and beliefs of Singaporean Chinese toward an ocular implant for glaucoma drug delivery.

PURPOSE We investigated patients' attitudes and perceptions toward a subconjunctival implant as a novel ocular drug delivery method for glaucoma. METHODS We recruited 344 Chinese patients with primary open angle or angle closure glaucoma currently on topical antiglaucoma medication for a minimum of six months from specialist glaucoma clinics. Sociodemographic data, and information about patients' general and ocular health were collected. Beliefs about medicines, glaucoma, eye drops, and self-reported adherence were assessed by trained interviewers using validated questionnaires. A description about the implant was provided and patients subsequently were assessed on their understanding and acceptance. RESULTS Of the 344 Chinese patients enrolled, 216 (62.8%) would accept the implant as a replacement for their current eye drops. Of those who accepted the implant, 99 (45.8%) were willing to accept it at similar costs, while 40 (18.5%) and 20 (9.3%) patients were willing to pay 1.5 and 2 times the cost of their present medication, respectively. Patients who accepted the implant had more severe glaucoma (P = 0.015) and felt that the implant was more helpful than eye drops (P < 0.001). Beliefs toward medicines, glaucoma, eye drops, self-reported adherence, and sociodemographic factors did not have a significant impact on the patients' decisions. CONCLUSIONS An ocular drug implant would be an acceptable alternative to topical eye drops for subgroups of glaucoma patients.

[1]  M. Ang,et al.  Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye , 2012, International journal of nanomedicine.

[2]  D. Pascolini,et al.  Global estimates of visual impairment: 2010 , 2011, British Journal of Ophthalmology.

[3]  M. Ang,et al.  Sustained Release of an Anti-Glaucoma Drug: Demonstration of Efficacy of a Liposomal Formulation in the Rabbit Eye , 2011, PloS one.

[4]  K. Pesudovs,et al.  Vision-specific quality-of-life research: a need to improve the quality. , 2011, American journal of ophthalmology.

[5]  Paul P. Lee,et al.  Health literacy and ophthalmic patient education. , 2010, Survey of ophthalmology.

[6]  Mark S Humayun,et al.  Mini Drug Pump for Ophthalmic Use , 2009, Current eye research.

[7]  J. Tsai.  A comprehensive perspective on patient adherence to topical glaucoma therapy. , 2009, Ophthalmology.

[8]  H. Quigley,et al.  Adherence and persistence with glaucoma therapy. , 2008, Survey of ophthalmology.

[9]  Seyedeh Seddigheh Fatemi,et al.  Attitudes of patients and family members towards implantable psychiatric medication , 2008, Schizophrenia Research.

[10]  E. Lavik,et al.  Sustained delivery of timolol maleate from poly(lactic-co-glycolic acid)/poly(lactic acid) microspheres for over 3 months , 2008, Journal of microencapsulation.

[11]  H. Ward,et al.  Predictive Validity of a Medication Adherence Measure in an Outpatient Setting , 2008, Journal of clinical hypertension.

[12]  S. Hahn,et al.  Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). , 2007, Investigative ophthalmology & visual science.

[13]  A. Sönnerborg,et al.  Adherence to treatment in Swedish HIV‐infected patients , 2006, Journal of clinical pharmacy and therapeutics.

[14]  Elizabeth Broadbent,et al.  The brief illness perception questionnaire. , 2006, Journal of psychosomatic research.

[15]  B. Svarstad,et al.  Patient-reported behavior and problems in using glaucoma medications. , 2006, Ophthalmology.

[16]  A. Hammond,et al.  Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis. , 2005, Rheumatology.

[17]  J. Tsai,et al.  Current and emerging medical therapies for glaucoma , 2005, Expert opinion on emerging drugs.

[18]  P. Khaw,et al.  Primary open-angle glaucoma , 2004, The Lancet.

[19]  B. Turetsky,et al.  Patient Attitudes towards Surgically Implantable, Long-Term Delivery of Psychiatric Medicine , 2004, Neuropsychopharmacology.

[20]  M. Dimatteo.  Variations in Patients’ Adherence to Medical Recommendations: A Quantitative Review of 50 Years of Research , 2004, Medical care.

[21]  J. Pichert,et al.  Compliance Barriers in Glaucoma: A Systematic Classification , 2003, Journal of glaucoma.

[22]  Ruxandra Gref,et al.  The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[23]  H. Jampel,et al.  Patient preferences for eye drop characteristics: a willingness-to-pay analysis. , 2003, Archives of ophthalmology.

[24]  C. Alvarez‐Lorenzo,et al.  Timolol uptake and release by imprinted soft contact lenses made of N,N-diethylacrylamide and methacrylic acid. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[25]  M. Robin DiMatteo,et al.  Patient Adherence and Medical Treatment Outcomes: A Meta-Analysis , 2002, Medical care.

[26]  B. Prum,et al.  The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration , 2000 .

[27]  F. M. Ali,et al.  Prolonged effect of liposomes encapsulating pilocarpine HCl in normal and glaucomatous rabbits. , 2000, International journal of pharmaceutics.

[28]  J. Weinman,et al.  Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. , 1999, Journal of psychosomatic research.

[29]  C. Rand,et al.  Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. , 1999, Medical care.

[30]  Douglas R. Anderson,et al.  The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. , 1998, American journal of ophthalmology.

[31]  L. Green,et al.  Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence , 1986, Medical care.

[32]  R. Horne,et al.  Beliefs about medicines predict refill adherence to inhaled corticosteroids. , 2008, Journal of psychosomatic research.

[33]  R. P. Mills,et al.  Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. , 2006, American journal of ophthalmology.

[34]  J. Weinman,et al.  The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication , 1999 .